Physician profile
Michael William Mann
NPI 1316985583
$12,863.75
in general payments reported to CMS, 2019-2025
44 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,728 · 2020: $2,103 · 2021: $1,985 · 2022: $1,975 · 2023: $1,689 · 2024: $2,149 · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,071.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,482.60 | 2019-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals Lp | $1,404.50 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $1,353.10 | 2020-2025 | |
| Novo Nordisk INC | $1,037.01 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $831.98 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $628.97 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $589.45 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $578.87 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $484.21 | 2021-2025 | |
| Allergan, INC. | $455.55 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $426.40 | 2019-2024 | Xarelto |
| Axsome Therapeutics, INC. | $409.89 | 2024-2025 | Auvelity, Sunosi |
| Amarin Pharma, INC. | $386.82 | 2019-2022 | |
| Antares Pharma, INC. | $273.36 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $241.24 | 2021-2024 | Nuzyra |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.